Bain Capital Life Sciences Investors, LLC

Bain Capital Life Sciences Investors, LLC is listed in filings as 10% Owner at Olema Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 22, 2026, including purchase activity and sale activity. Recent filings connect the profile to Olema Pharmaceuticals, Inc. (OLMA), NewAmsterdam Pharma Company N.V. (NAMS), Heartflow, Inc. Common Stock (HTFL), and Rapid Micro Biosystems, Inc. (RPID). The current snapshot covers public activity from Dec 17, 2024 to May 22, 2026. Reported amounts are shown as $350 to $163. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.